Financial Impact of Health Care‐associated Infections: When Money Talks | Zendy

Louis Valiquette | Zendy; Claire Nour Abou Chakra | Zendy; Kevin B. Laupland | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Financial Impact of Health Care‐associated Infections: When Money Talks

Author(s) -

Louis Valiquette,

Claire Nour Abou Chakra,

Kevin B. Laupland

Publication year - 2014

Publication title -

canadian journal of infectious diseases and medical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 38

eISSN - 1918-1493

pISSN - 1712-9532

DOI - 10.1155/2014/279794

Subject(s) - medicine , health care , infection control , incidence (geometry) , pneumonia , health spending , environmental health , emergency medicine , disease control , antibiotic resistance , intensive care medicine , antibiotics , health services , population , economics , economic growth , physics , microbiology and biotechnology , optics , biology

According to the Canadian Institute for Health Information, health spending in Canada was projected to reach $211 billion in 2013 (versus $207 billion in 2012), corresponding to $5,988 per per-son (1). Overall, this represents 11.2% of Canada’s gross domestic product. Approximately 60% of total health spending is directed to hospitals (30%), drugs (16%) and physicians (15%). Although it is difficult to estimate, the proportion of this spending attributed to the management of nosocomial infections, overuse and/or misuse of antimicrobials, and infections due to multidrug-resistant bacteria is significant. Despite the availability of efficient strategies targeting each of these aspects, large-scale progress has not been demonstrated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research